PAMAfrica

Portfolio approach to developing the next-generation of malaria treatments for Africa

First malaria medicine for young infants 2-5 kg receives approval

Coartem® Baby launches in Ghana

Timothy Wells visits CISM researchers in Mozambique

MMV’s Timothy Wells visits CISM researchers in Mozambique to discuss lessons and advances in malaria

Delivering better healthcare outcomes through PAMAfrica’s CALINA study

MMV and and Novartis announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria

SwissCore: PAMAfrica’s role in the global fight against malaria

The Guardian: Could new malaria drug give babies a better chance of survival?

Take a look at our infographic!

Take a look at our infosheet!

Photo: Alex Radelich

Portfolio approach to developing the next-generation of malaria treatments for Africa

Work packages

Next-generation drug combination for uncomplicated malaria

First malaria treatment for young infants 2-5 kg

New medicine for treatment of severe malaria

Strengthening research capacity in Africa

PAMAfrica scientists

Consortium Partners

MMV

Medicines for Malaria Venture (MMV) is a leading product development partnership (PDP) in antimalarial drug research in its 20th year.

Novartis

Novartis is reimagining medicine to improve and extend people’s lives.

Merck

Merck, a leading science and technology company, operates across life science, healthcare and electronics.

The Eberhard Karls Universität Tübingen

The Eberhard Karls Universität Tübingen is one of Europe’s oldest universities, with key strengths in Sciences and Life Sciences. Within the Faculty of Medicine, the Institute of Tropical Medicine (ITM) is an established Centre of Excellence (since 2007).

CERMEL

ISGlobal

The ultimate goal of ISGlobal is to help close the gaps in health disparities between and within different regions of the world.

Manhiça Health Research Centre

Manhiça Health Research Centre is a research institution managed by Manhiça Foundation, whose mission is to promote and conduct biomedical research in health priority areas to promote and safeguard the health of the population.

GRAS

The Groupe de Recherche Action en Santé (GRAS) is a private institute based in Burkina Faso, operating since 2008 in the field of health research.

IDRC

IDRC conducts research in infectious diseases including Malaria, HIV, Tuberculosis and other diseases of public health importance through collaboration and partnership.